Home/Filings/4/0000899243-21-014105
4//SEC Filing

Hindman James M. 4

Accession 0000899243-21-014105

CIK 0001740547other

Filed

Mar 30, 8:00 PM ET

Accepted

Mar 31, 12:30 PM ET

Size

10.7 KB

Accession

0000899243-21-014105

Insider Transaction Report

Form 4
Period: 2021-03-29
Transactions
  • Disposition to Issuer

    Common Shares

    2021-03-299,0000 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2021-03-2961,0000 total
    Exercise: $10.53Exp: 2030-06-01Common Shares (61,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2021-03-2915,0000 total
    Exercise: $9.38Exp: 2030-07-21Common Shares (15,000 underlying)
Footnotes (2)
  • [F1]Immediately prior to the consummation of the Merger, these securities were time-based restricted share units ("RSUs") subject to vesting and previously granted pursuant to the Issuer's 2017 Equity Incentive Plan. Upon the consummation of the Merger, each RSU, whether vested or unvested, that had not been settled in common shares of the Issuer ("Common Shares") prior to the effective time of the Merger was canceled and converted automatically into the right to receive $16.25 per each such RSU, without interest and less any applicable withholding for taxes, as described in the Merger Agreement.
  • [F2]Upon consummation of the Merger, each option to purchase Common Shares that was outstanding and unexercised immediately prior to the effective time of the Merger, whether vested or unvested, and that had an exercise price per Common Share that is less than $16.25 was cancelled and automatically converted into the right to receive a cash amount for each Common Share that is subject to such option that is equal to the difference between $16.25 and the per share exercise price of such option, without interest and less any applicable withholding for taxes, as described in the Merger Agreement.

Issuer

Urovant Sciences Ltd.

CIK 0001740547

Entity typeother

Related Parties

1
  • filerCIK 0001617615

Filing Metadata

Form type
4
Filed
Mar 30, 8:00 PM ET
Accepted
Mar 31, 12:30 PM ET
Size
10.7 KB